The results were presented at the San Antonio Breast Cancer Symposium (SABCS) in San .... INDUSTRY KEYWORD: ONCOLOGY HEALTH CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY.
News
- Oncternal Therapeutics Announces Presentation of Interim Clinical Data on Cirmtuzumab in ...
- SABCS: 10-year study shows targeted radiation can be as effective as whole-breast doses against ...
A 10-year clinical trial of over 4,200 patients presented at the annual San Antonio symposium last year also found that it was unable to reject the idea ...
- Silverback Therapeutics Announces Preclinical Data at 2019 San Antonio Breast Cancer ...
Silverback Therapeutics, Inc., a biopharmaceutical company developing a pipeline of systemically delivered, locally active therapies, announced the ...
- Traders Are Bearish Anixa Biosciences, Inc. (ANIX) After The Stock Formed Bearish Multiple ...
The stock of Anixa Biosciences, Inc. (ANIX) shows a multiple bottoms pattern ... “Anixa Biosciences Announces Presentation at the 2019 San Antonio ...
- Recon: FDA Authorizes First Newborn DMD Screening Test; Amgen, UCB Osteoporosis Drug ...
Pharmaceutical & Biotechnology: Study Results, Filings & Designations ... Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of ... Drug Delivery Technology To Be Presented At San Antonio Breast Cancer ...